Works matching DE "SUNITINIB"
Results: 266
The efficacy of second-line tyrosine kinase inhibitor for patients with metastatic non-clear cell renal cell carcinoma following first-line immune-oncology combination therapy.
- Published in:
- World Journal of Urology, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s00345-024-05252-2
- By:
- Publication type:
- Article
PDIA4 在肾癌细胞舒尼替尼耐药中的作用研究.
- Published in:
- Progress in Modern Biomedicine, 2024, v. 24, n. 13, p. 2408, doi. 10.13241/j.cnki.pmb.2024.13.002
- By:
- Publication type:
- Article
An evaluation of the clinical and treatment features of renal cell carcinoma.
- Published in:
- Journal of Experimental & Clinical Medicine / Deneysel ve Klinik Tip Dergisi, 2024, v. 41, n. 2, p. 294, doi. 10.52142/omujecm.41.2.12
- By:
- Publication type:
- Article
In Vitro Cytotoxicity of Antiresorptive and Antiangiogenic Compounds on Oral Tissues Contributing to MRONJ: Systematic Review.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 6, p. 973, doi. 10.3390/biom13060973
- By:
- Publication type:
- Article
PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancer.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1343004
- By:
- Publication type:
- Article
Sintilimab combined with axitinib in the treatment of advanced chromophobe renal cell carcinoma: a case report.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1325999
- By:
- Publication type:
- Article
Case Report: A novel TP53 mutation in a patient with quadruple wild-type gastrointestinal stromal tumor.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1260706
- By:
- Publication type:
- Article
Corrigendum: Long non-coding RNA CCAT1 acts as an oncogene and promotes sunitinib resistance in renal cell carcinoma.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1247057
- Publication type:
- Article
Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1223282
- By:
- Publication type:
- Article
Cost-effectiveness and budget impact of pembrolizumab +axitinib versus sunitinib in patients with advanced clear-cell renal cell carcinoma in the Netherlands.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1205700
- By:
- Publication type:
- Article
Clinical progress of anti-angiogenic targeted therapy and combination therapy for gastric cancer.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1148131
- By:
- Publication type:
- Article
The chromosomal instability 25 gene signature is identified in clear cell renal cell carcinoma and serves as a predictor for survival and Sunitinib response.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1133902
- By:
- Publication type:
- Article
Case report: Abolishing primary resistance to PD-1 blockade by short-term treatment of lenvatinib in a patient with advanced metastatic renal cell carcinoma.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1115691
- By:
- Publication type:
- Article
The cuproptosis-associated 13 gene signature as a robust predictor for outcome and response to immune- and targeted-therapies in clear cell renal cell carcinoma.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.971142
- By:
- Publication type:
- Article
Comprehensive Analysis of Senescence Characteristics Defines a Novel Prognostic Signature to Guide Personalized Treatment for Clear Cell Renal Cell Carcinoma.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.901671
- By:
- Publication type:
- Article
Sunitinib promotes apoptosis via p38 MAPK activation and STAT3 downregulation in oral keratinocytes.
- Published in:
- Oral Diseases, 2024, v. 30, n. 2, p. 639, doi. 10.1111/odi.14457
- By:
- Publication type:
- Article
Effect of tyrosine kinase inhibitor sunitinib on tissue repair at tooth extraction sites.
- Published in:
- Oral Diseases, 2023, v. 29, n. 3, p. 1070, doi. 10.1111/odi.14065
- By:
- Publication type:
- Article
Clinical outcomes by baseline metastases in patients with renal cell carcinoma treated with lenvatinib plus pembrolizumab versus sunitinib: Post hoc analysis of the CLEAR trial.
- Published in:
- International Journal of Cancer, 2025, v. 156, n. 7, p. 1326, doi. 10.1002/ijc.35288
- By:
- Publication type:
- Article
Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trial.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 6, p. 1241, doi. 10.1002/ijc.34608
- By:
- Publication type:
- Article
Combination of pimitespib (TAS‐116) with sunitinib is an effective therapy for imatinib‐resistant gastrointestinal stromal tumors.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 12, p. 2580, doi. 10.1002/ijc.34461
- By:
- Publication type:
- Article
Special issue "The advance of solid tumor research in China": Prediction of Sunitinib efficacy using computed tomography in patients with pancreatic neuroendocrine tumors.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 1, p. 90, doi. 10.1002/ijc.34294
- By:
- Publication type:
- Article
Cabozantinib‐nivolumab sequence in metastatic renal cell carcinoma: The CABIR study.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 8, p. 1335, doi. 10.1002/ijc.34126
- By:
- Publication type:
- Article
Dyskerin and telomerase RNA component are sex-differentially associated with outcomes and Sunitinib response in patients with clear cell renal cell carcinoma.
- Published in:
- Biology of Sex Differences, 2023, v. 14, n. 1, p. 1, doi. 10.1186/s13293-023-00526-7
- By:
- Publication type:
- Article
Vorolanib, sunitinib, and axitinib: A comparative study of vascular endothelial growth factor receptor inhibitors and their anti-angiogenic effects.
- Published in:
- PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0304782
- By:
- Publication type:
- Article
Blocking stanniocalcin 2 reduces sunitinib resistance in clear cell renal cell carcinoma.
- Published in:
- Neoplasma, 2022, v. 69, n. 1, p. 145, doi. 10.4149/neo_2021_210823N1206
- By:
- Publication type:
- Article
Therapeutic strategies for patients with neuroendocrine neoplasms: current perspectives.
- Published in:
- Expert Review of Endocrinology & Metabolism, 2022, v. 17, n. 5, p. 389, doi. 10.1080/17446651.2022.2099840
- By:
- Publication type:
- Article
Involvement of Ferroptosis Induction and Oxidative Phosphorylation Inhibition in the Anticancer-Drug-Induced Myocardial Injury: Ameliorative Role of Pterostilbene.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 5, p. 3015, doi. 10.3390/ijms25053015
- By:
- Publication type:
- Article
Pterostilbene Induces Apoptosis from Endoplasmic Reticulum Stress Synergistically with Anticancer Drugs That Deposit Iron in Mitochondria.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 5, p. 2611, doi. 10.3390/ijms25052611
- By:
- Publication type:
- Article
Investigation of Gastrointestinal Toxicities Associated with Concurrent Abdominal Radiation Therapy and the Tyrosine Kinase Inhibitor Sunitinib in a Mouse Model.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 3, p. 1838, doi. 10.3390/ijms25031838
- By:
- Publication type:
- Article
An Overview of the Use of Anti-Angiogenic Agents in the Treatment of Thymic Epithelial Tumors.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 23, p. 17065, doi. 10.3390/ijms242317065
- By:
- Publication type:
- Article
LIX1 Controls MAPK Signaling Reactivation and Contributes to GIST-T1 Cell Resistance to Imatinib.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 8, p. 7138, doi. 10.3390/ijms24087138
- By:
- Publication type:
- Article
An In Vitro Analysis of TKI-Based Sequence Therapy in Renal Cell Carcinoma Cell Lines.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 6, p. 5648, doi. 10.3390/ijms24065648
- By:
- Publication type:
- Article
Anticancer Activity of Sunitinib Analogues in Human Pancreatic Cancer Cell Cultures under Normoxia and Hypoxia.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 6, p. 5422, doi. 10.3390/ijms24065422
- By:
- Publication type:
- Article
Study of siRNA Delivery via Polymeric Nanoparticles in Combination with Angiogenesis Inhibitor for The Treatment of AFP -Related Liver Cancer.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 20, p. 12666, doi. 10.3390/ijms232012666
- By:
- Publication type:
- Article
Development of a Sensitive Screening Method for Simultaneous Determination of Nine Genotoxic Nitrosamines in Active Pharmaceutical Ingredients by GC-MS.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 20, p. 12125, doi. 10.3390/ijms232012125
- By:
- Publication type:
- Article
Sunitinib versus Pazopanib Dilemma in Renal Cell Carcinoma: New Insights into the In Vitro Metabolic Impact, Efficacy, and Safety.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 17, p. 9898, doi. 10.3390/ijms23179898
- By:
- Publication type:
- Article
LPPR5 Expression in Glioma Affects Growth, Vascular Architecture, and Sunitinib Resistance.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 6, p. 3108, doi. 10.3390/ijms23063108
- By:
- Publication type:
- Article
Efficacy and safety analysis of TACE + sunitinib vs. sunitinib in the treatment of unresectable advanced renal cell carcinoma: a retrospective study.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10754-0
- By:
- Publication type:
- Article
Prognostic model for overall survival that includes the combination of platelet count and neutrophil-lymphocyte ratio within the first six weeks of sunitinib treatment for metastatic renal cell carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Hemangiopericytoma of the skull base: A long‑term complete response with trimodality treatment.
- Published in:
- Indian Journal of Cancer, 2024, v. 61, n. 2, p. 337, doi. 10.4103/ijc.IJC_207_21
- By:
- Publication type:
- Article
2/1 dose schedule of sunitinib is superior than the 4/2 regimen for the first-line therapy of clear cell metastatic renal cell carcinoma - An Indian experience.
- Published in:
- Indian Journal of Cancer, 2023, v. 60, n. 4, p. 493, doi. 10.4103/ijc.IJC_1284_20
- By:
- Publication type:
- Article
Sunitinib suppresses M2 polarization of macrophages in tumor microenvironment to regulate hepatocellular carcinoma progression.
- Published in:
- Journal of Biochemical & Molecular Toxicology, 2023, v. 37, n. 6, p. 1, doi. 10.1002/jbt.23333
- By:
- Publication type:
- Article
The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCC.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 9, p. 2151, doi. 10.1007/s00262-022-03146-z
- By:
- Publication type:
- Article
Molecular characterization, clinical value, and cancer–immune interactions of genes related to disulfidptosis and ferroptosis in colorectal cancer.
- Published in:
- Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01031-y
- By:
- Publication type:
- Article
Sunitinib alleviates hepatic ischemia reperfusion injury by inhibiting the JAK2/STAT pathway and promoting the M2 polarization of macrophages.
- Published in:
- Immunopharmacology & Immunotoxicology, 2024, v. 46, n. 5, p. 672, doi. 10.1080/08923973.2024.2390455
- By:
- Publication type:
- Article
Advanced renal cancer as a chronic disease — long-term disease control with a tyrosine kinase inhibitor (TKI) inhibitor.
- Published in:
- Nowotwory, 2024, v. 74, n. 5, p. 337, doi. 10.5603/njo.101194
- By:
- Publication type:
- Article
Outcomes of treatment, laboratory results, adverse effects, and tolerability of cancer treatment in patients with metastatic renal-cell carcinoma treated with sunitinib after cytoreductive nephrectomy.
- Published in:
- Nowotwory, 2024, v. 74, n. 2, p. 105, doi. 10.5603/njo.98971
- By:
- Publication type:
- Article
Multi-omics and immunogenomics analysis revealed PFKFB3 as a targetable hallmark and mediates sunitinib resistance in papillary renal cell carcinoma: in silico study with laboratory verification.
- Published in:
- European Journal of Medical Research, 2024, v. 29, n. 1, p. 1, doi. 10.1186/s40001-024-01808-5
- By:
- Publication type:
- Article
[Corrigendum] Chloroquine potentiates the anticancer effect of sunitinib on renal cell carcinoma by inhibiting autophagy and inducing apoptosis.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
An Unusual Cause of Splinter Hemorrhages: Herpes Zoster Infection.
- Published in:
- Balkan Medical Journal, 2023, v. 40, n. 5, p. 378, doi. 10.4274/balkanmedj.galenos.2023.2023-6-50
- By:
- Publication type:
- Article